USE OF MEGESTROL ACETATE HAVING IMPROVED SOLUBILITY FOR THE TREATMENT OF CANCER CACHEXIA
摘要
<p>The present invention relates to the treatment of cancer patients suffering from cachexia as a co-morbidity with a megestrol acetate formulation (MegaceTM ES) having improved solubility.</p>
申请公布号
WO2009056256(A1)
申请公布日期
2009.05.07
申请号
WO2008EP08967
申请日期
2008.10.23
申请人
PAR PHARMACEUTICALS, INC.;ANKER, STEFAN;SPRINGER, JOCHEN
